Comparative efficacy and safety of fimasartan in patients with hypertension: A network meta‐analysis of randomized controlled trials

Hypertension is a prevalent risk factor for cardiovascular disease. Angiotensin II receptor blockers are widely prescribed to patients with hypertension, while new drugs are continuously developed. However, data on comparative efficacy and safety of novel agents, such as fimasartan, are scarce. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Suk Min, Ihm, Sang Hyun, Yi, Jeong‐Eun, Jeong, Seung Hee, Kim, Bong‐Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380168/
https://www.ncbi.nlm.nih.gov/pubmed/35819029
http://dx.doi.org/10.1111/jch.14536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380168/
https://www.ncbi.nlm.nih.gov/pubmed/35819029
http://dx.doi.org/10.1111/jch.14536

Ejemplares similares